Detalhe da pesquisa
1.
Towards maximum acceleration of monoclonal antibody development: Leveraging transposase-mediated cell line generation to enable GMP manufacturing within 3 months using a stable pool.
J Biotechnol
; 349: 53-64, 2022 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35341894